A Pan‐Enterovirus Natural Product Inhibitor Targeting a Unique Allosteric Site on the Viral 3C Protease
Advanced Biology · 2025
DOI: 10.1002/adbi.202400845 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Biology, 2025. Verfasst von Shangwu Sun und 5 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Institute for Advanced Immunochemical Studies and School of Life Science and Technology, ShanghaiTech University, Shanghai, 201210, China. Hauptthemen laut MEDLINE: Enterovirus, 3C Viral Proteases, Antiviral Agents, Biological Products. Die Arbeit nennt 47 Literaturangaben. Gefördert von: Science and Technology Commission of Shanghai Municipality, National Natural Science Foundation of China.
Abstract (Originalsprache)
Infections caused by Enterovirus like rhinoviruses, coxsackieviruses, and polioviruses represent a significant public health concern, for which there are no antivirals available yet. The highly conserved viral 3C protease has been the primary target for antiviral development, but competitive inhibitors targeting its active site does not meet expectations in clinical studies. Previously, an unconventional allosteric site is identified on human rhinovirus 14 (HRV14) 3C, representing novel opportunities for pan‐enterovirus antivirals development. Here, in silico screening of 143,621 natural products against this allosteric site is performed and 28 candidate molecules are identified, among which dihydromyricetin (DHM) and oridonin‐A1 bind to HRV14 3C and allosterically inhibit its protease activity. Moreover, DHM shows minimal cytotoxicity and potent antiviral efficacy against HRV14 infections across different cell models, with selective indexes exceeding 700. Structural analysis and mutagenesis assays further pinpoint key 3C residues essential for DHM binding. Consistent with the high conservation of these residues across Enterovirus genus, DHM broadly binds and efficiently inhibits 3C proteases from not only rhinoviruses, but also coxsackieviruses, enteroviruses and polioviruses. These findings establish DHM as a unique, broad‐spectrum allosteric inhibitor of Enterovirus 3C proteases and underscore its potential as a promising candidate for the development of pan‐enterovirus antivirals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shanghai Institute for Advanced Immunochemical Studies and School of Life Science and Technology, ShanghaiTech University, Shanghai, 201210, China.
- Shanghai Clinical Research and Trial Center, Shanghai, 201210, China.
- Shanghai Frontiers Science Center for Biomacromolecules and Precision Medicine, ShanghaiTech University, Shanghai, 200031, China.
ORCID-Profile: Bei Yang
Förderung
- Science and Technology Commission of Shanghai Municipality
- National Natural Science Foundation of China
Zitieren
APA
Sun, S., Wang, Q., Zhu, M., Zhang, X., Zhang, X., & Yang, B. (2025). A Pan‐Enterovirus Natural Product Inhibitor Targeting a Unique Allosteric Site on the Viral 3C Protease. Advanced Biology. https://doi.org/10.1002/adbi.202400845
Vancouver
Sun S, Wang Q, Zhu M, Zhang X, Zhang X, Yang B. A Pan‐Enterovirus Natural Product Inhibitor Targeting a Unique Allosteric Site on the Viral 3C Protease. Advanced Biology. 2025. doi:10.1002/adbi.202400845
BibTeX
@article{Sun2025,
author = {Sun, Shangwu and Wang, Qiang and Zhu, Mengyao and Zhang, Xuan and Zhang, Xianfang and Yang, Bei},
title = {A Pan‐Enterovirus Natural Product Inhibitor Targeting a Unique Allosteric Site on the Viral 3C Protease},
journal = {Advanced Biology},
year = {2025},
doi = {10.1002/adbi.202400845}
}
EUVIMED